These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 15651145)

  • 1. [Dyslipidemia at the turn of the century: optimism or scepticism?].
    Soska V
    Vnitr Lek; 2004 Oct; 50 Suppl 1():S71-5. PubMed ID: 15651145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statins and diabetes.
    Carmena R; Betteridge DJ
    Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inadequate management of dyslipidaemic patients in France. Results of the Odyssée study].
    Ferrières J; Elbaz M; Maupas E; Carriè D; Puel J
    Arch Mal Coeur Vaiss; 2004 Mar; 97(3):187-93. PubMed ID: 15106741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opportunity for intervention to achieve American Heart Association guidelines for optimal lipid levels in high-risk women in a managed care setting.
    Mosca L; Merz NB; Blumenthal RS; Cziraky MJ; Fabunmi RP; Sarawate C; Watson KE; Willey VJ; Stanek EJ
    Circulation; 2005 Feb; 111(4):488-93. PubMed ID: 15687138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of hyperlipidemia in primary practise in Germany: sub-group analyses from the 4E-registry with particular emphasis on men and women with diabetes mellitus.
    Assmann G; Schulte H; Cullen P; Neiss A; Bestehorn K
    Exp Clin Endocrinol Diabetes; 2007 Feb; 115(2):85-91. PubMed ID: 17318766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Quality of therapeutic control of hyperlipidemias in secondary prevention of coronary heart disease in the light of current recommendations].
    Mayer O; Mayer O
    Vnitr Lek; 2004 Oct; 50(10):777-80. PubMed ID: 15633934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines improve general trend of lowered cholesterol levels in type 2 diabetes patients in spite of low adherence.
    Fhärm E; Rolandsson O; Weinehall L
    Scand J Public Health; 2008 Jan; 36(1):69-75. PubMed ID: 18426787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary prevention trials: lessons learned about treating high-risk patients with dyslipidemia without known cardiovascular disease.
    Ferdinand KC
    Curr Med Res Opin; 2005 Jul; 21(7):1091-7. PubMed ID: 16004678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Achievement of guideline-defined treatment goals in primary care: the German Coronary Risk Management (CoRiMa) study.
    Geller JC; Cassens S; Brosz M; Keil U; Bernarding J; Kropf S; Bierwirth RA; Lippmann-Grob B; Schultheiss HP; Schlüter K; Pels K
    Eur Heart J; 2007 Dec; 28(24):3051-8. PubMed ID: 18029365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid management in patients with diabetes mellitus.
    Brown AS
    Am J Cardiol; 2005 Aug; 96(4A):26E-32E. PubMed ID: 16098840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrates and future PPARalpha agonists in the treatment of cardiovascular disease.
    Staels B; Maes M; Zambon A
    Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):542-53. PubMed ID: 18628776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factor control in patients with Type 2 diabetes and coronary heart disease: findings from the Swedish National Diabetes Register (NDR).
    Gudbjörnsdottir S; Eeg-Olofsson K; Cederholm J; Zethelius B; Eliasson B; Nilsson PM;
    Diabet Med; 2009 Jan; 26(1):53-60. PubMed ID: 19125761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Achieving vascular risk factor targets: a survey of a London general practice.
    Levine AP; Mikhailidis DP; Moross T; Benson K; Gor M
    Angiology; 2008; 59(1):36-46. PubMed ID: 18319220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hypolipidemic drugs and diabetes mellitus].
    Bláha V; Mistrík E
    Vnitr Lek; 2009 Apr; 55(4):357-62. PubMed ID: 19449750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postprandial lipemia: an under-recognized atherogenic factor in patients with diabetes mellitus.
    Pastromas S; Terzi AB; Tousoulis D; Koulouris S
    Int J Cardiol; 2008 May; 126(1):3-12. PubMed ID: 17689745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indications for lowering LDL cholesterol in rheumatoid arthritis: an unrecognized problem.
    Soubrier M; Zerkak D; Dougados M
    J Rheumatol; 2006 Sep; 33(9):1766-9. PubMed ID: 16845709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic risk factor treatment of peripheral arterial disease is lacking and requires vascular surgeon participation.
    Bianchi C; Montalvo V; Ou HW; Bishop V; Abou-Zamzam AM
    Ann Vasc Surg; 2007 Mar; 21(2):163-6. PubMed ID: 17349357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary prevention for acute coronary syndrome in rural South Australia: are drugs best? What about the rest?
    Wachtel TM; Kucia AM; Greenhill JA
    Rural Remote Health; 2008; 8(4):967. PubMed ID: 18855517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review article: hyperlipidaemia and cardiovascular risk.
    Bertolotti M; Maurantonio M; Gabbi C; Anzivino C; Carulli N
    Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():28-30. PubMed ID: 16225468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.